// App-Quantinova.ai

: Optimisation of novel small molecule inhibitors of SRPK1‐mediated VEGF‐A splicing through modelling of permeability properties required for trans‐scleral eye drop delivery

Researchers

Presenter

  • J. Batson

Principal Investigators

  • H. Toop

  • J. Daubney

  • S. Liddell

  • E. Stewart

  • J. Bourne

  • Z. Blackley

  • J. Morris

  • D.O. Bates

Medical Centers

  • Exonate Ltd, Exonate, Nottingham, UK

  • Exonate Ltd, University of New South Wales, Sydney, Australia

  • School of Medicine, University of Nottingham, Nottingham, United Kingdom

Locations

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Vascular endothelial growth factor A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved